BIOSTAR PHARM-B (02563)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Meng Songdong29-Apr-26INEDResignation due to the requirements of his principal employer.
Zhu Pai23-May-25NEDResignation to devote more time to other commitments.
Ran Dong10-Apr-25INEDMr. Ran Dong resigned to focus on his other personal commitments. His major concern was the uncertainty regarding the redemption of a US$5 million fund investment, which delayed the publication of the Company's 2024 results.
Qi Jingyao26-Mar-25INEDResignation to focus on her other personal commitments.